Can pharmacists help end HIV? new study trains louisiana pharmacists to prescribe PrEP

NCT ID NCT06530225

Not yet recruiting Prevention Sponsor: Xavier University of Louisiana. Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jul 31, 2026 · Updated 2 times

Summary

This study will train 75 Louisiana pharmacists to prescribe PrEP, a daily pill that prevents HIV. The training includes lessons on health disparities and implicit bias, plus mentoring. Researchers want to see if this increases the number of PrEP prescriptions, especially in communities that often miss out on HIV prevention.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Education and mentoring program for pharmacists
What this could lead to: If successful, this could expand PrEP access in Louisiana and reduce HIV infection rates, especially in underserved communities.
What could go wrong: This is a small, early-stage study (75 pharmacists) focused on training, not patient outcomes. It may not show a direct impact on HIV prevention or be scalable.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV PREVENTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

HIV infectious disease prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIV PREVENTION

Contacts and locations

Locations

Xavier University of Louisiana

New Orleans, Louisiana, 70125, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.